0001209191-21-004102.txt : 20210119 0001209191-21-004102.hdr.sgml : 20210119 20210119182914 ACCESSION NUMBER: 0001209191-21-004102 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210115 FILED AS OF DATE: 20210119 DATE AS OF CHANGE: 20210119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wright-Mitchell Jane CENTRAL INDEX KEY: 0001614568 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39323 FILM NUMBER: 21536830 MAIL ADDRESS: STREET 1: C/0 ACELRX PHARMACEUTICALS, INC. STREET 2: 351 GALVESTON DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 FORMER NAME: FORMER CONFORMED NAME: Mitchell Jane Wright DATE OF NAME CHANGE: 20140723 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vaxcyte, Inc. CENTRAL INDEX KEY: 0001649094 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 464233385 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 353 HATCH DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 650-837-0111 MAIL ADDRESS: STREET 1: 353 HATCH DR CITY: FOSTER CITY STATE: CA ZIP: 94404 FORMER COMPANY: FORMER CONFORMED NAME: SutroVax, Inc. DATE OF NAME CHANGE: 20150724 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-15 0 0001649094 Vaxcyte, Inc. PCVX 0001614568 Wright-Mitchell Jane C/O VAXCYTE, INC. 353 HATCH DRIVE FOSTER CITY CA 94404 0 1 0 0 General Counsel Common Stock 2021-01-15 4 M 0 2500 2.03 A 4062 D Common Stock 2021-01-15 4 S 0 2500 26.00 D 1562 D Stock Option (right to buy) 2.03 2021-01-15 4 M 0 2500 0.00 D 2029-03-20 Common Stock 2500 204968 D Includes 1,562 shares acquired under the Employee Stock Purchase Plan on November 17, 2020. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. 1/4 of the shares subject to the option vested on January 7, 2020, and 1/48 of the shares vest monthly thereafter. /s/ Winston Macaraeg, Attorney-in-Fact 2021-01-19